Financial Services
Star Health and Allied Insurance Company Limited (STARHEALTH) breaks out, moves up 6% intraday
Star Health and Allied Insurance Company Limited (STARHEALTH) stock breaks out, gaining 6% intraday to ₹571.0, clearing its 6M resistance trendline.
Star Health and Allied Insurance Company Limited (STARHEALTH) breaks out with a +6% gain to ₹571.0 on the NSE on 18 Jun 2026, clearing its 6M resistance trendline. This move follows the company’s recent NSE filings on shareholders meetings, which may have provided clarity and confidence to investors. In the insurance sector, STARHEALTH’s breakout is notable as it indicates a potential shift in market sentiment, though it remains to be seen if this is a broader sector trend or company-specific momentum.
Technical setup — trendlines & DMA
The current 6M trendline structure shows STARHEALTH has broken out above its resistance at ₹528.85, now trading 7.38% higher. The 6M support trendline stands at ₹514.31, which is 9.93% below today’s price, indicating a solid buffer if pullbacks occur. The 50-DMA at ₹513.1 is above the 200-DMA at ₹477.4, signaling a bullish trend. The stock is currently in the upper third of its 52W range, suggesting that a substantial portion of the recent gains may already be priced in, though there is still room for further upside given its position relative to the 52W high.
Snapshot: ₹571.00 on 2026-06-18 (chart frozen at publication)
Fundamentals & business context
With a PE of 56.2 and profit margins at 3.1%, STARHEALTH’s valuation appears stretched relative to its current earnings, especially given the revenue CAGR of 13.3% and profit CAGR of -3.4%. This suggests that the market may be pricing in expectations of a turnaround or future growth, which is not yet reflected in the current profitability. The 23.8% institutional ownership indicates that smart money has a measured interest in the company, likely betting on its long-term potential rather than immediate returns. There was no specific NSE catalyst today, but the overall market sentiment and technical breakout may have contributed to the move.
Algorithmic scorecard
The overall algorithmic scorecard of 71 reflects a technically strong but fundamentally weaker position. Two of the strongest signals are the bullish trend, with the 50-DMA above the 200-DMA, and the stock’s low volatility, indicated by a beta of 0.20, which suggests stability and less market risk. On the flip side, the two weakest signals are the low profit margin of 3.1%, which leaves little room for error, and the negligible dividend yield of 0%, offering little to no income to shareholders. These contrasting signals highlight the stock’s potential for growth alongside its inherent risks.
Company outlook
Management outlined several key points for the upcoming quarters. They expect NEP growth to align with GWP growth, signaling a potential improvement in profitability. Additionally, there is an anticipated improvement in volume-based retention by 1% to 1.5% annually. The company will continue to focus on profitable geographies and consumer cohorts, aiming for sustainable high-teen growth and mid-teen to high-teen ROEs. These strategic initiatives indicate a clear path for enhancing both growth and profitability in the near term.
Get all details on STARHEALTH — P&L, peers, shareholding and more on TradeAlone.
Capital Markets
Motilal Oswal Financial Services Limited (motilalofs) Gets IND Aa+/stable Rating Upgrade by India Ratings
Motilal Oswal Financial Services Limited (MOTILALOFS) receives IND AA+/Stable upgrade from India Ratings, reflecting stronger business profile.
Motilal Oswal Financial Services Limited (MOTILALOFS) announced that India Ratings and Research (Ind-Ra), a Fitch Group company, has upgraded the long-term credit rating of the company and its key subsidiaries to ‘IND AA+’ with a Stable Outlook, from ‘IND AA’ with a Positive Outlook. The upgrade applies to the non-convertible debentures (NCDs) and bank loan facilities of MOFSL and Motilal Oswal Home Finance Limited (MOHFL), and to the NCDs of Motilal Oswal Finvest Limited (MOFL). Ind-Ra has also affirmed the ‘IND A1+’ rating on the commercial paper programmes of MOFSL, MOFL and Motilal Oswal Wealth Limited (MOWL).
Stronger Business Profile
According to Ind-Ra, the upgrade reflects a stronger business profile, driven by the continued scale-up of its asset management and private wealth businesses, rising recurring fee-based revenue, and sustained profitability growth visibility across key operating segments. The agency noted that improved earnings diversification has reduced the group’s relative dependence on transaction-based income, while comfortable capitalisation, adequate liquidity buffers, and the fungibility of liquidity across group entities provide additional financial flexibility.
Future Prospects
A stronger rating widens our access to diversified funding and should support greater efficiency in our cost of borrowing as we scale our lending, housing finance, and wealth businesses with discipline, said Mr. Shalibhadra Shah, Group Chief Financial Officer, Motilal Oswal Financial Services Limited. With this rating upgrade, we are now rated AA+ from all the three leading rating agencies in India.
The upgrade is an independent recognition of the transformation of Motilal Oswal, said Mr. Motilal Oswal, Managing Director and CEO & co-founder, Motilal Oswal Financial Services Limited. This upgrade belongs to the more than 15 million clients who trust us, to our franchise partners, and to our people, and it strengthens our resolve to build an institution that compounds trust as patiently as it compounds wealth.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Motilal Oswal Financial Services Limited
Motilal Oswal Financial Services Limited belongs to the Financial Services › Capital Markets sector. Here’s a quick read on where the business and the stock stand today.
Motilal holds in the upper half of its 52-week range, a sign the market backs the stock. D/E of 1.32 is elevated. As a result, debt servicing will compress free cash flow in a high-rate environment. Premium net margins of 23.0% demonstrate strong cost discipline and a wide competitive moat. Buyers show up with 1.8x the volume of sellers. Moreover, they dominated on 16 of recent sessions versus 14 for sellers — a healthy accumulation pattern. Both the business and the stock move in the right direction. Revenue grows at 29.1%, profits at 26.1%, and the PEG sits at 1.12 — below its growth rate. That combination is rare. Check Fundamentals of Motilal Oswal Financial Services Limited.
Banks - Regional
Indusind Bank Limited Expands HYROX India Partnership to Multiple Cities
IndusInd Bank Limited (INDUSINDBK) expands its partnership with HYROX India, offering exclusive benefits to customers across multiple cities.
IndusInd Bank Limited (INDUSINDBK) has expanded its partnership with HYROX India, spanning across multiple cities including Ahmedabad, Bengaluru, and Noida. This strategic move aims to strengthen the bank’s connection with fitness enthusiasts and experience-seeking consumers, offering exclusive cashback offers and race-day benefits.
Exclusive Benefits for Customers
Customers will enjoy priority check-in, dedicated access lanes, exclusive event privileges, and curated on-ground experiences. This partnership reflects IndusInd Bank’s commitment to engaging with a generation that values aspiration, perseverance, and continuous progress.
Strategic Partnership
Speaking on the partnership, Sheran Mehra, Chief Marketing Officer, IndusInd Bank, said, ‘HYROX gives IndusInd Bank an opportunity to engage with a generation that values aspiration, perseverance, and continuous progress. This partnership is therefore more than a sports association; it is a strategic platform to deepen relevance, create distinctive experiences, and become part of the lives of consumers who are always striving for what’s next.’
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of IndusInd Bank Limited
IndusInd Bank Limited belongs to the Financial Services › Banks – Regional sector. Here’s a quick read on where the business and the stock stand today.
IndusInd posts a 2.2% three-month gain, but softens in the last few weeks. Thin margins at 7.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue contracts at -0.4% CAGR. That signals structural headwinds, not a short-term blip. The stock gives back 6.3% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at -0.4% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of IndusInd Bank Limited.
Credit Services
Ugro Capital Raises INR 380 Crore from FMO; Third Investment in Three Years Deepens Development Finance Backing for India’s MSME Credit Gap
Ugro Capital Limited (UGROCAP) secures INR 380 crore from FMO, marking its third investment in three years, to support India’s MSME sector.
UGRO Capital Limited (NSE: UGROCAP) announced today that it has raised INR 380 crore through the issuance of senior, secured, rated, listed, redeemable and transferable Non-Convertible Debentures (NCDs), fully subscribed by Nederlandse Financierings-Maatschappij voor Ontwikkelingslanden N.V. (FMO), the Dutch entrepreneurial development bank. This marks FMO’s third investment in UGRO Capital in under three years, following NCD investments of INR 250 crore in December 2023 and INR 260 crore in February 2025. The five-year tenor of the new instrument matches the long-duration secured lending that UGRO extends to small businesses in Tier-3 towns and beyond.
Strategic Investment
The investment continues UGRO Capital’s strategy of building a diversified, long-tenor institutional funding base that is less dependent on the domestic banking system. The Company has now raised over INR 1,300 crore of debt from development finance institutions and impact-focused investors in India and globally, including FMO, IFU, the Danish sovereign development fund, the Asian Development Bank (ADB), Triple Jump, BlueOrchard, responsAbility, Calvert Impact Capital, Enabling Qapital, GMO, WaterEquity and MicroVest, among others.
Impactful Financing
In line with FMO’s mandate, the proceeds will be deployed towards financing for women-owned and women-led SMEs, youth-owned and youth-led SMEs and rural SMEs, and will also contribute towards the financing or refinancing of eligible green projects aligned with FMO’s sustainability approach. UGRO Capital serves the segment of Indian enterprise that the formal credit system has historically been unable to reach: businesses with turnover below INR 3 crore that lack the tax and audited records conventional lenders require.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Ugro Capital Limited
Ugro Capital Limited belongs to the Financial Services › Credit Services sector. Here’s a quick read on where the business and the stock stand today.
Ugro falls 14.1% over three months and has not found a floor yet. The PEG of 0.09 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Premium net margins of 24.0% demonstrate strong cost discipline and a wide competitive moat. RSI stands at 29, well into oversold territory. Yet sellers still dominated on 19 of recent sessions versus 11 for buyers, so the pressure has not fully lifted. Revenue grows at 42.4% and profits at 63.8% CAGR, with D/E of 0.00. Meanwhile, the stock dips 14.1% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Ugro Capital Limited.
-
CUMMINSIND3 days agoCummins India Limited (cumminsind) Unveils Next-generation Power Solutions at Bauma Conexpo India 2026
-
Industrials2 days agoWestern Carriers (india) Limited Launches Bulk Tiles Train at Morbi Terminal
-
Auto Parts3 days agoUno Minda Limited Announces Four Major Strategic Expansions with ₹1,415 Crore Investment
-
AUROPHARMA3 days agoAurobindo Pharma Limited Receives Final Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
-
CARTRADE3 days agoCartrade Tech Limited (cartrade) Expands OLX India’s Elite Buyer for Businesses
-
Basic Materials2 days agoS H Kelkar and Company Limited (SHK) Mourns the Loss of Chairman Mr. Ramesh Vinayak Vaze
-
EMBDL3 days agoEmbassy Developments Limited (embdl) Launches Embassy Origins in North Bengaluru
-
Credit Services3 days agoMuthoot Microfin Limited (muthootmf) Secures ₹250 Crore Through Ncds to Drive Growth Plans
